Clearing harmful old cells with CAR T immune cells

Deconstructing aging with senolytic CAR T cells

['FUNDING_OTHER'] · COLD SPRING HARBOR LABORATORY · NIH-11184345

This project uses engineered CAR T immune cells to find and remove senescent (old, damaged) cells that build up with age and can drive age-related problems.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorCOLD SPRING HARBOR LABORATORY (nih funded)
Locations1 site (COLD SPRING HARBOR, UNITED STATES)
Trial IDNIH-11184345 on ClinicalTrials.gov

What this research studies

From a patient perspective, researchers are looking for proteins on the surface of senescent cells that appear during aging so they can better identify and isolate those cells. They will study the biology of these senescent cells and use the identified surface markers to design CAR T immune cells that selectively target and kill them. The work will be done in the lab and in preclinical models at Cold Spring Harbor Laboratory to test how well the approach clears senescent cells and reduces inflammation. The ultimate aim is to pave the way for therapies that reduce tissue damage and dysfunction tied to accumulated senescent cells.

Who could benefit from this research

Good fit: Ideal candidates would be older adults with age-related conditions thought to be driven by accumulated senescent cells, though the project is currently preclinical.

Not a fit: Young healthy people or patients whose conditions are unrelated to cellular senescence are unlikely to benefit from this work in the near term.

Why it matters

Potential benefit: If successful, this could lead to treatments that remove harmful senescent cells and reduce inflammation and decline from age-related conditions.

How similar studies have performed: Related senolytic drugs and some preclinical CAR T approaches have shown promise in lab and animal studies, but CAR T targeting of senescent cells for aging remains largely novel.

Where this research is happening

COLD SPRING HARBOR, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.